Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in ...
Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Three years after its initial FDA approval, Roche has made up for an early disadvantage with its blood cancer drug Lunsumio amid competition among CD20xCD3 bispecific antibodies. The FDA has approved ...
Mosunetuzumab's subcutaneous formulation offers a 1-minute injection, improving convenience over the previous intravenous infusion for relapsed or refractory follicular lymphoma. The phase 1/2 GO29781 ...
A year after an FDA rejection, Johnson & Johnson has won approval for a more convenient version of its lung cancer drug Rybrevant to better challenge AstraZeneca’s Tagrisso. Rybrevant Faspro, a ...
Rodeo is an attending surgeon and vice chair of orthopedic research at the Hospital for Special Surgery and head team physician for the New York Giants. It’s hard to miss the buzz around regenerative ...
The FDA has approved the use of subcutaneous amivantamab and hyaluronidase-lpuj across all amivantamab indications. The FDA has approved the use of subcutaneous amivantamab and hyaluronidase-lpuj ...
Botox can cause temporary redness, swelling, tenderness, or bruising at the injection site. You may get flu-like symptoms like fever, body aches, or nausea after Botox. Botox may cause headaches, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback